Patents by Inventor Craig L. Hyde

Craig L. Hyde has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090186347
    Abstract: Correlations between polymorphisms and metabolic syndrome, insulin resistance, obesity, high blood pressure, dyslipidemia, diabetes and/or myocardial infarction are provided. Methods of diagnosing and treating metabolic syndrome, insulin resistance, obesity, high blood pressure, dyslipidemia, diabetes and/or myocardial infarction are provided. Systems and kits for diagnosis and treatment of metabolic syndrome, insulin resistance, obesity, high blood pressure, dyslipidemia, diabetes and/or myocardial infarction are provided.
    Type: Application
    Filed: May 9, 2008
    Publication date: July 23, 2009
    Inventors: David R. Cox, Kelly A. Frazer, David A. Hinds, Craig L. Hyde, John F. Thompson
  • Publication number: 20080299125
    Abstract: The invention provides a collection of polymorphic sites associated with response to treatment by an SSRI or placebo in depression patients. The polymorphic sites and others in linkage disequilibrium with them are useful in determining whether to treat a patient with an SSRI or include a patient in a clinical trial to test an SSRI.
    Type: Application
    Filed: June 5, 2007
    Publication date: December 4, 2008
    Applicant: Perlegen Sciences, Inc.
    Inventors: David A. Hinds, David R. Cox, Craig L. Hyde, Hakan Sakul
  • Patent number: 7060444
    Abstract: Disclosed are methods of identifying toxic agents, e.g., hepatotoxic agents, using differential gene expression.
    Type: Grant
    Filed: September 15, 2003
    Date of Patent: June 13, 2006
    Assignee: CuraGen Corporation
    Inventors: Denise A. McCabe, Oswald R. Crasta, Darius M. Dziuda, Craig L. Hyde, Robert Gerwien